Research community previously filed under “Molecular Biology”

Gene Therapy, Genome Editing and Circadian Biology

Mostly in the field Ion Channel Physiology, Cellular Imaging, and Neurodevelopmental Health (44% of its papers), one of 7 communities there

Papers 17,038
Elements —
Keywords & sectors 5
Leading venue Journal of Biological Chemistry

Gene Therapy, Genome Editing and Circadian Biology

This community focuses on developing genetic therapies for rare diseases and understanding the molecular mechanisms of the body's internal clock.

The work centers on three distinct but related areas. First, the development of gene therapies and enzyme replacement treatments for specific conditions, with a heavy emphasis on Pompe disease and alpha-1 antitrypsin deficiency. This involves the use of adeno-associated viruses (AAV) and hematopoietic stem cells to deliver functional genes or correct defects. Second, the application of genome editing tools, particularly CRISPR-Cas9 and zinc finger proteins, to modify DNA and regulate gene expression in human and mouse models. Third, the study of circadian clock genes and their role in physiology, including how disruptions to this timing system affect health and disease. These threads are connected by the shared use of molecular biology techniques to manipulate genetic information for therapeutic or mechanistic insight.

The community is most prominent in research tracked for Zinc, where it constitutes 0.2% of all Zinc-related papers, and Sodium, where it accounts for 0.1% of Sodium-related papers. It also appears in research for Phosphorus, Sulfur, Oxygen, Calcium, Nitrogen, and Bromine, with smaller shares in each.

There are 17,038 papers in this community, with the majority published in the Journal of Biological Chemistry, Molecular Therapy, and Human Gene Therapy.

Recent work includes the development of retargeted serine integrases for precise DNA integration in human cells, the use of hematopoietic stem cell gene editing to create B lymphocyte protein factories, and the study of direct cell-to-cell transmission of retrotransposons.

Recurring themes in the literature

Phrases that recur across this community's paper titles -- a quick map of its sub-topics, drawn straight from the titles themselves.

  • gene therapy 338
  • pompe disease 313
  • circadian clock 187
  • zinc finger 138
  • alpha-1 antitrypsin 129
  • stem cell 99
  • genome editing 91
  • antitrypsin deficiency 89
  • stem cells 87
  • transposable element 86
  • crispr cas9 65
  • gene editing 59
  • hematopoietic stem 59
  • gene expression 57
  • late-onset pompe 53
  • replacement therapy 52
  • enzyme replacement 52
  • adeno-associated virus 50
  • cell cycle 48
  • mouse model 48
  • pluripotent stem 48
  • case report 47
  • clock gene 40
  • finger protein 39

Papers behind this description

Most cited
Nature · 2024 · 178 citations
Cell · 2023 · 195 citations
Signal Transduction and Targeted Therapy · 2022 · 457 citations
Signal Transduction and Targeted Therapy · 2020 · 1713 citations
International Journal of Molecular Sciences · 2023 · 173 citations
Newest
Cell · 2026 · 19 citations
Nature Biotechnology · 2026 · 17 citations
Nature Methods · 2026 · 10 citations
FEBS Journal · 2026 · 9 citations
International Journal of Molecular Sciences · 2026 · 12 citations

A sample from the 18 papers behind this description. Create a free account to see them all.